XML 69 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER EXPENSE (INCOME), NET
 12 Months Ended
Dec. 31, 2023
Other Income and Expenses [Abstract]  
OTHER EXPENSE (INCOME), NET OTHER EXPENSE (INCOME), NET
Other expense (income), net, were as follows:
Year Ended December 31,
(in millions)202320222021
Foreign exchange transaction (gain) loss
$(3)$6 $(12)
Other expense (income), net12 47 14 
Total other expense (income), net$9 $53 $2 

The Company’s equity-method net losses were $4 million, $36 million, and $10 million for the years ended December 31, 2023, 2022, and 2021, respectively. Loss from equity method investments for the year ended December 31, 2022 includes $36 million recorded in Other expense (income), net in the Consolidated Statements of Operations for a write-off of the Company’s ownership position in a privately-held dental investment company following impairment of underlying investments held by the investment company and the Company’s determination that the remaining investment is not recoverable.
On February 1, 2021, the Company disposed of an investment casting business previously included as part of the former Consumables segment in exchange for a cash receipt of $19 million. The divestiture resulted in a pre-tax gain of $13 million recorded in Other expense (income), net in the Consolidated Statements of Operations for the year ended December 31, 2021.